Home > Healthcare > Medical Devices > Diagnostic Devices > Urinalysis Market

Urinalysis Market Analysis

Report ID: GMI439
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Urinalysis Market Analysis

Urinalysis Market Size, By Product, 2021-2032 (USD Billion)

Based on product, the urinalysis market size from the consumables segment is anticipated to grow at 4.6% CAGR from 2023-2032. The growth can be attributed to the rising frequency of regular checkup cycles driven by the growing awareness of the importance of early illness identification. In addition, the increasing technological improvements have led to the development of creative and user-friendly consumables. The growing acceptance of dipsticks for renal illness, pregnancy, and diabetes detection will also add to the segment expansion.

Urinalysis Market Share, By Application, 2022

Learn more about the key segments shaping this market

Download Free Sample

In terms of application, the urinalysis market from the urinary tract infections (UTI) segment accounted for USD 1.4 billion in revenue in 2022 and is anticipated to record considerable growth through 2032. The high frequency of UTIs worldwide will increase the demand for diagnostic testing. The growing awareness regarding the difficulties associated with untreated UTIs as well as the importance of early identification and treatment has resulted in the rising importance of urine testing. Furthermore, the higher availability and accessibility of early illness diagnosis to reduce the burden of UTI diseases in developed and emerging nations will influence the market trends.

Based on end-use, the urinalysis market from the hospital segment garnered 38.7% revenue share in 2022 and is anticipated to expand at notable CAGR from 2023 to 2032 owing to the growing preference for urinalysis as the initial diagnostic tool to treat a variety of disorders in hospitals. In addition, the presence of innovative technologies, such as automated urine analyzers for precise diagnosis in these facilities as well as qualified staff will foster the segment demand.

U.S. Urinalysis Market Size, 2020-2032 (USD Billion)

Looking for region specific data?

Download Free Sample

North America held 36% share in the urinalysis market in 2022 and is set to reach USD 2.3 billion by 2032. The robust presence of key market players and well-established healthcare systems with advanced healthcare facilities are contributing to the increasing adoption of advanced urinalysis technologies in the region. Furthermore, the high prevalence of chronic kidney diseases and diabetes coupled with the growing emphasis on personalized medicines will positively impact the market share.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Urinalysis industry was valued at USD 3.8 billion in 2022 and is expected to exhibit 5.2% CAGR from 2023 to 2032 owing to the increasing demand for better diagnostic and treatment techniques to treat the rising incidence rate of urinary tract infections globally.

Urinalysis industry size from the consumables product segment amassed USD 2.7 billion in 2022 and is poised to expand at 4.6% CAGR from 2023-2032 owing to the growing technological improvements.

North America held 36% share of the global urinalysis market in 2022 and is expected to expand at notable pace through 2032 driven by the strong presence of key market players and well-established healthcare systems.

Some of the top companies operating in the urinalysis industry are Bio-Rad Laboratories, Inc, Cardinal Health, ARKRAY Inc., ACON Laboratories, Inc., Abbott Laboratories, Sysmex Corporation, Teco Diagnostics, Erba Mannheim, Siemens Healthineers, 77 Elektronika Kft, and F.Hoffmann-La Roche Ltd.